Bing Chen
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Inflammatory Biomarkers in Disease Prognosis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 29
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 5
- Inflammatory Biomarkers in Disease Prognosis 4
- Cancer Cells and Metastasis 3
- Colorectal Cancer Screening and Detection 3
- Colorectal Cancer Treatments and Studies 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Peipei Xu (7 shared papers)Jian Ouyang (3 shared papers)Ruju Wang (2 shared papers)Yong Hu (2 shared papers)Arsalan Ahmed (1 shared paper)Huaqin Zuo (1 shared paper)Pina M. Cardarelli (2 shared papers)Mark Selby (2 shared papers)
- Journals
- Scientific Reports (2 papers)PLoS ONE (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Journal of Clinical Oncology (2 papers)ACS Applied Nano Materials (1 paper)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Bing Chen
38 papers receiving 751 citations
Peers
Comparison fields: 5 of 98
- Oncology 358
- Immunology 163
- Hematology 57
- Cancer Research 68
- Biomaterials 59
Countries citing papers authored by Bing Chen
This map shows the geographic impact of Bing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Chen more than expected).
Fields of papers citing papers by Bing Chen
This network shows the impact of papers produced by Bing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Chen. The network helps show where Bing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 178 | |
| 2 | 2017 | 146 | |
| 3 | 2016 | 81 | |
| 4 | 2007 | 40 | |
| 5 | 2020 | 33 | |
| 6 | 2015 | 31 | |
| 7 | 2018 | 25 | |
| 8 | 2023 | 24 | |
| 9 | 2023 | 21 | |
| 10 | 2016 | 21 | |
| 11 | 2019 | 21 | |
| 12 | 1999 | 20 | |
| 13 | 2022 | 18 | |
| 14 | 2020 | 13 | |
| 15 | 2024 | 9 | |
| 16 | 2021 | 9 | |
| 17 | 2019 | 9 | |
| 18 | 2013 | 8 | |
| 19 | 2020 | 8 | |
| 20 | [Tissue engineered tendon with skin fibroblasts as seed cells, a preliminary study]. | 2002 | 6 |
About Bing Chen
Bing Chen is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Hematology, having authored 43 papers that have together received 764 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (3 papers), Colorectal Cancer Screening and Detection (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (358 citations), Immunology (163 citations), Hematology (57 citations), Cancer Research (68 citations) and Biomaterials (59 citations). Bing Chen has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Peipei Xu, Jian Ouyang, Ruju Wang, Yong Hu, Arsalan Ahmed, Huaqin Zuo, Pina M. Cardarelli, Mark Selby, Changyu Wang and Alan J. Korman. Their work appears in journals such as Scientific Reports, PLoS ONE, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology and ACS Applied Nano Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.